310 related articles for article (PubMed ID: 26647737)
1. Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients.
Yan L; Zhang H; Ma H; Liu D; Li W; Kang Y; Yang R; Wang J; He G; Xie X; Wang H; Wei L; Lu Z; Shao Q; Chen H
Sci Rep; 2015 Dec; 5():17950. PubMed ID: 26647737
[TBL] [Abstract][Full Text] [Related]
2. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
Yang HC; Chen CL; Shen YC; Peng CY; Liu CJ; Tseng TC; Su TH; Chuang WL; Yu ML; Dai CY; Liu CH; Chen PJ; Chen DS; Kao JH
Hepatology; 2013 Mar; 57(3):934-43. PubMed ID: 23112104
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
[TBL] [Abstract][Full Text] [Related]
5. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.
Chuaypen N; Payungporn S; Poovorawan K; Chotiyaputta W; Piratvisuth T; Tangkijvanich P
Virus Genes; 2019 Oct; 55(5):610-618. PubMed ID: 31359359
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers.
Qin Y; Zhang J; Mao R; Guo H; Yin Y; Wu X; Weng X; Wands J; Tong S
J Med Virol; 2009 May; 81(5):807-14. PubMed ID: 19319958
[TBL] [Abstract][Full Text] [Related]
8. Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B.
Liu Y; Zhong Y; Zou Z; Xu Z; Li B; Ren X; Bai S; Wang L; Li X; Dai J; Wang Y; Mao P; Xu D
J Clin Virol; 2010 Mar; 47(3):243-7. PubMed ID: 20080060
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients.
Yan CH; Zhao CY; Ding H; Peng YQ; Jin PY; Yan L; Zhuang H; Li T
Antiviral Res; 2012 Nov; 96(2):108-14. PubMed ID: 22960603
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.
Xiao L; Zhou B; Gao H; Ma S; Yang G; Xu M; Abbott WG; Chen J; Sun J; Wang Z; Hou J
J Med Virol; 2011 Sep; 83(9):1544-50. PubMed ID: 21739444
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.
Ren X; Xu Z; Liu Y; Li X; Bai S; Ding N; Zhong Y; Wang L; Mao P; Zoulim F; Xu D
J Viral Hepat; 2010 Dec; 17(12):887-95. PubMed ID: 20070500
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of mutations in basal core promoter and precore region of hepatitis B virus in vaccinated and nonvaccinated individuals of the aboriginal Nicobarese tribe of Car Nicobar Island, India.
Bhattacharya H; Bhattacharya D; Nagarajan M; Reesu R; Roy S; Attayur PS
Intervirology; 2014; 57(6):357-64. PubMed ID: 25323975
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B.
Lin CL; Liao LY; Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
J Gastroenterol; 2002; 37(4):283-7. PubMed ID: 11993512
[TBL] [Abstract][Full Text] [Related]
14. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
Kamijo N; Matsumoto A; Umemura T; Shibata S; Ichikawa Y; Kimura T; Komatsu M; Tanaka E
World J Gastroenterol; 2015 Jan; 21(2):541-8. PubMed ID: 25593470
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants.
Gao S; Joshi SS; Osiowy C; Chen Y; Coffin CS; Duan ZP
Virol J; 2017 Oct; 14(1):203. PubMed ID: 29065883
[TBL] [Abstract][Full Text] [Related]
16. Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion.
Nie H; Evans AA; London WT; Block TM; Ren XD
J Hepatol; 2012 Apr; 56(4):795-802. PubMed ID: 22173170
[TBL] [Abstract][Full Text] [Related]
17. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
Xu L; Chen EQ; Lei J; Liu L; Zhou TY; Gao Z; Tang H
Hepatogastroenterology; 2012; 59(113):212-5. PubMed ID: 22251541
[TBL] [Abstract][Full Text] [Related]
18. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
Chauhan R; Kazim SN; Bhattacharjee J; Sakhuja P; Sarin SK
J Med Virol; 2006 Aug; 78(8):1047-54. PubMed ID: 16789012
[TBL] [Abstract][Full Text] [Related]
19. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
[TBL] [Abstract][Full Text] [Related]
20. Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.
Ducancelle A; Pivert A; Bertrais S; Boursier J; Balan V; Veillon P; le Guillou-Guillemette H; Thibault V; Castelain S; Roquebert B; Coste-Burel M; Mackiewicz V; Schvoerer E; Larrat S; Maylin S; Alain S; Loustaud-Ratti V; Gordien E; Gozlan J; Brodard V; Chevaliez S; Calès P; Lunel-Fabiani F
J Gastroenterol Hepatol; 2016 Oct; 31(10):1750-1756. PubMed ID: 26992056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
